{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T18:07:20Z","timestamp":1770919640198,"version":"3.50.1"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T00:00:00Z","timestamp":1770163200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T00:00:00Z","timestamp":1770854400000},"content-version":"vor","delay-in-days":8,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82100757"],"award-info":[{"award-number":["82100757"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Shanghai JiaoTong University K.C.Wong Medical Fellowship Fund"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"DOI":"10.1186\/s12882-026-04802-7","type":"journal-article","created":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T08:06:14Z","timestamp":1770192374000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Renal biopsy findings in psoriasis patients with renal involvement: a descriptive clinicopathologic study"],"prefix":"10.1186","volume":"27","author":[{"given":"Chenyang","family":"Qi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lihong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pingyan","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xia","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoxia","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingyuan","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,4]]},"reference":[{"issue":"1","key":"4802_CR1","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1590\/abd1806-4841.20164169","volume":"91","author":"J Machado-Pinto","year":"2016","unstructured":"Machado-Pinto J, Diniz MS, Bavoso NC. Psoriasis: new comorbidities. An Bras Dermatol. 2016;91(1):8\u201314.","journal-title":"An Bras Dermatol"},{"issue":"6","key":"4802_CR2","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1111\/1346-8138.15840","volume":"48","author":"F Yamazaki","year":"2021","unstructured":"Yamazaki F. Psoriasis: comorbidities. J Dermatol. 2021;48(6):732\u201340.","journal-title":"J Dermatol"},{"issue":"5","key":"4802_CR3","first-page":"438","volume":"18","author":"A Conti","year":"2020","unstructured":"Conti A, Giovannini L, Mandel VD, Odorici G, Lasagni C, Bigi L, Pellacani G, Cappelli G. Chronic kidney disease in psoriasis: a cohort study. JDDG: J Der Deutschen Dermatologischen Gesellschaft. 2020;18(5):438\u201345.","journal-title":"JDDG: J Der Deutschen Dermatologischen Gesellschaft"},{"issue":"5","key":"4802_CR4","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1111\/bjd.14961","volume":"176","author":"SK Grewal","year":"2017","unstructured":"Grewal SK, Wan J, Denburg MR, Shin DB, Takeshita J, Gelfand JM. The risk of IgA nephropathy and glomerular disease in patients with psoriasis: a population-based cohort study. Br J Dermatol. 2017;176(5):1366\u20139.","journal-title":"Br J Dermatol"},{"issue":"5","key":"4802_CR5","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1111\/j.1365-2133.2011.10494.x","volume":"165","author":"YW Yang","year":"2011","unstructured":"Yang YW, Keller JJ, Lin HC. Medical comorbidity associated with psoriasis in adults: a population-based study. Br J Dermatol. 2011;165(5):1037\u201343.","journal-title":"Br J Dermatol"},{"issue":"1","key":"4802_CR6","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1111\/bjd.13599","volume":"173","author":"HY Chiu","year":"2015","unstructured":"Chiu HY, Huang HL, Li CH, Yin YJ, Chen HA, Hsu ST, Lin SJ, Tsai TF, Ho SY. Increased risk of glomerulonephritis and chronic kidney disease in relation to the severity of psoriasis, concomitant medication, and comorbidity: a nationwide population-based cohort study. Br J Dermatol. 2015;173(1):146\u201354.","journal-title":"Br J Dermatol"},{"issue":"oct15 7","key":"4802_CR7","doi-asserted-by":"publisher","first-page":"f5961","DOI":"10.1136\/bmj.f5961","volume":"347","author":"J Wan","year":"2013","unstructured":"Wan J, Wang S, Haynes K, Denburg MR, Shin DB, Gelfand JM. Risk of moderate to advanced kidney disease in patients with psoriasis: population based cohort study. BMJ. 2013;347(oct15 7):f5961\u20135961.","journal-title":"BMJ"},{"issue":"3","key":"4802_CR8","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.jdermsci.2015.03.012","volume":"78","author":"CC Chi","year":"2015","unstructured":"Chi CC, Wang J, Chen YF, Wang SH, Chen FL, Tung TH. Risk of incident chronic kidney disease and end-stage renal disease in patients with psoriasis: A nationwide population-based cohort study. J Dermatol Sci. 2015;78(3):232\u20138.","journal-title":"J Dermatol Sci"},{"key":"4802_CR9","doi-asserted-by":"crossref","unstructured":"Kharouf F, Gao S, Al-Matar S, Cook RJ, Chandran V, Gladman DD. Chronic kidney disease in patients with psoriatic arthritis: a cohort study. RMD Open. 2024;10(4).","DOI":"10.1136\/rmdopen-2024-004636"},{"issue":"28","key":"4802_CR10","doi-asserted-by":"publisher","first-page":"46381","DOI":"10.18632\/oncotarget.18453","volume":"8","author":"K Chen","year":"2017","unstructured":"Chen K, Wang G, Jin H, Xu J, Zhu X, Zheng M, Gu H. Clinic characteristics of psoriasis in china: a nationwide survey in over 12000 patients. Oncotarget. 2017;8(28):46381\u20139.","journal-title":"Oncotarget"},{"key":"4802_CR11","unstructured":"Working Group of the International Ig ANN, the, Renal Pathology S, Cattran DC, Coppo R, Cook HT, Feehally J, Roberts IS, Troyanov S, Alpers CE, Amore A et al. The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification. Kidney Int. 2009;76(5):534\u2013545."},{"issue":"5","key":"4802_CR12","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1053\/j.ajkd.2012.06.011","volume":"60","author":"CH Zeng","year":"2012","unstructured":"Zeng CH, Le W, Ni Z, Zhang M, Miao L, Luo P, Wang R, Lv Z, Chen J, Tian J, et al. A multicenter application and evaluation of the Oxford classification of IgA nephropathy in adult Chinese patients. Am J Kidney Dis. 2012;60(5):812\u201320.","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"4802_CR13","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1053\/j.ajkd.2018.01.043","volume":"72","author":"J Xie","year":"2018","unstructured":"Xie J, Lv J, Wang W, Li G, Liu Z, Chen H, Xu F, Sun J, Ouyang Y, Zhang X, et al. Kidney failure risk prediction equations in IgA nephropathy: A multicenter risk assessment study in Chinese patients. Am J Kidney Dis. 2018;72(3):371\u201380.","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"4802_CR14","doi-asserted-by":"publisher","first-page":"11151","DOI":"10.1038\/s41598-020-68087-y","volume":"10","author":"T Moriyama","year":"2020","unstructured":"Moriyama T, Karasawa K, Miyabe Y, Akiyama K, Ogura S, Takabe T, Sugiura N, Seki M, Iwabuchi Y, Uchida K, et al. Validation of the revised Oxford classification for IgA nephropathy considering treatment with corticosteroids\/immunosuppressors. Sci Rep. 2020;10(1):11151.","journal-title":"Sci Rep"},{"issue":"4","key":"4802_CR15","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1038\/ki.2014.63","volume":"86","author":"R Coppo","year":"2014","unstructured":"Coppo R, Troyanov S, Bellur S, Cattran D, Cook HT, Feehally J, Roberts IS, Morando L, Camilla R, Tesar V, et al. Validation of the Oxford classification of IgA nephropathy in cohorts with different presentations and treatments. Kidney Int. 2014;86(4):828\u201336.","journal-title":"Kidney Int"},{"issue":"5","key":"4802_CR16","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1159\/000332223","volume":"34","author":"T Yau","year":"2011","unstructured":"Yau T, Korbet SM, Schwartz MM, Cimbaluk DJ. The Oxford classification of IgA nephropathy: a retrospective analysis. Am J Nephrol. 2011;34(5):435\u201344.","journal-title":"Am J Nephrol"},{"issue":"3","key":"4802_CR17","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1038\/ki.1989.68","volume":"35","author":"HS Lee","year":"1989","unstructured":"Lee HS, Choi Y, Lee JS, Yu BH, Koh HI. Ultrastructural changes in IgA nephropathy in relation to histologic and clinical data. Kidney Int. 1989;35(3):880\u20136.","journal-title":"Kidney Int"},{"issue":"2","key":"4802_CR18","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1002\/path.1711500206","volume":"150","author":"N Yoshikawa","year":"1986","unstructured":"Yoshikawa N, Yoshiara S, Yoshiya K, Matsuo T, Okada S. Lysis of the glomerular basement membrane in children with IgA nephropathy and Henoch-Shonlein nephritis. J Pathol. 1986;150(2):119\u201326.","journal-title":"J Pathol"},{"issue":"6","key":"4802_CR19","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1038\/ki.1982.224","volume":"22","author":"A multicenter study of IgA nephropathy in children","year":"1982","unstructured":"A multicenter study of IgA nephropathy in children. A report of the Southwest pediatric nephrology study group. Kidney Int. 1982;22(6):643\u201352.","journal-title":"Kidney Int"},{"issue":"9","key":"4802_CR20","first-page":"1033","volume":"35","author":"T Sasaki","year":"1993","unstructured":"Sasaki T. [Electron microscopy study on alterations of glomerular basement membrane in IgA nephropathy]. Nihon Jinzo Gakkai Shi. 1993;35(9):1033\u201341.","journal-title":"Nihon Jinzo Gakkai Shi"},{"key":"4802_CR21","doi-asserted-by":"crossref","unstructured":"Stamellou E, Seikrit C, Tang SCW, Boor P, Tesa\u0159 V, Floege J, Barratt J, Kramann R. IgA nephropathy. Nat Reviews Disease Primers. 2023;9(1).","DOI":"10.1038\/s41572-023-00476-9"},{"issue":"12","key":"4802_CR22","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.1093\/ndt\/gfz152","volume":"35","author":"CA Cassol","year":"2020","unstructured":"Cassol CA, Bott C, Nadasdy GM, Alberton V, Malvar A, Nagaraja HN, Nadasdy T, Rovin BH, Satoskar AA. Immunostaining for galactose-deficient Immunoglobulin A is not specific for primary Immunoglobulin A nephropathy. Nephrol Dial Transpl. 2020;35(12):2123\u20139.","journal-title":"Nephrol Dial Transpl"},{"key":"4802_CR23","doi-asserted-by":"crossref","unstructured":"Cao W, Xiong J. Causal associations and potential mechanisms between inflammatory skin diseases and IgA nephropathy: a bi-directional Mendelian randomization study. Front Genet. 2024;15.","DOI":"10.3389\/fgene.2024.1402302"},{"issue":"1","key":"4802_CR24","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1080\/0886022X.2017.1419972","volume":"40","author":"J-R Lin","year":"2018","unstructured":"Lin J-R, Wen J, Zhang H, Wang L, Gou F-F, Yang M, Fan J-M. Interleukin-17 promotes the production of underglycosylated IgA1 in DAKIKI cells. Ren Fail. 2018;40(1):60\u20137.","journal-title":"Ren Fail"},{"issue":"1","key":"4802_CR25","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41572-025-00630-5","volume":"11","author":"AW Armstrong","year":"2025","unstructured":"Armstrong AW, Blauvelt A, Callis Duffin K, Huang Y-H, Savage LJ, Guo L, Merola JF. Psoriasis. Nat Reviews Disease Primers. 2025;11(1):45.","journal-title":"Nat Reviews Disease Primers"},{"issue":"1","key":"4802_CR26","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa0810457","volume":"361","author":"LH Beck Jr","year":"2009","unstructured":"Beck LH Jr., Bonegio RG, Lambeau G, Beck DM, Powell DW, Cummins TD, Klein JB, Salant DJ. M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med. 2009;361(1):11\u201321.","journal-title":"N Engl J Med"},{"issue":"6","key":"4802_CR27","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1681\/ASN.2010090967","volume":"22","author":"W Qin","year":"2011","unstructured":"Qin W, Beck LH Jr., Zeng C, Chen Z, Li S, Zuo K, Salant DJ, Liu Z. Anti-phospholipase A2 receptor antibody in membranous nephropathy. J Am Soc Nephrol. 2011;22(6):1137\u201343.","journal-title":"J Am Soc Nephrol"},{"key":"4802_CR28","doi-asserted-by":"publisher","first-page":"958136","DOI":"10.3389\/fphar.2022.958136","volume":"13","author":"A Perna","year":"2022","unstructured":"Perna A, Ruggiero B, Podesta MA, Perico L, Orisio S, Debiec H, Remuzzi G, Ruggenenti P. Sexual dimorphic response to rituximab treatment: A longitudinal observational study in a large cohort of patients with primary membranous nephropathy and persistent nephrotic syndrome. Front Pharmacol. 2022;13:958136.","journal-title":"Front Pharmacol"},{"issue":"4","key":"4802_CR29","doi-asserted-by":"publisher","first-page":"257","DOI":"10.4103\/0971-4065.160334","volume":"26","author":"N Gopalakrishnan","year":"2016","unstructured":"Gopalakrishnan N, Abeesh P, Dineshkumar T, Murugananth S, Sakthirajan R, Raman GS, Dhanapriya J, Balasubramaniyan T, Haris M. Prevalence of serum anti M-type phospholipase A2 receptor antibody in primary membranous nephropathy: A single center experience. Indian J Nephrol. 2016;26(4):257\u201361.","journal-title":"Indian J Nephrol"},{"issue":"1","key":"4802_CR30","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s12882-021-02338-6","volume":"22","author":"M Arghiani","year":"2021","unstructured":"Arghiani M, Zamani BH, Nazemian F, Samadi S, Afsharian MS, Habibzadeh M, Eslami S, Sabbagh MG. A cohort study of membranous nephropathy, primary or secondary. BMC Nephrol. 2021;22(1):138.","journal-title":"BMC Nephrol"},{"issue":"1","key":"4802_CR31","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1080\/0886022X.2020.1792315","volume":"42","author":"P Yin","year":"2020","unstructured":"Yin P, Wang J, Liang W, Zhan L, Liu Y, Lin J, Chen X, He Y, Jian H, Xie Z, et al. Outcomes of primary membranous nephropathy based on serum anti-phospholipase A2 receptor antibodies and glomerular phospholipase A2 receptor antigen status: a retrospective cohort study. Ren Fail. 2020;42(1):675\u201383.","journal-title":"Ren Fail"},{"issue":"9","key":"4802_CR32","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1093\/ndt\/gfv399","volume":"31","author":"R Ramachandran","year":"2016","unstructured":"Ramachandran R, Kumar V, Kumar A, Yadav AK, Nada R, Kumar H, Kumar V, Rathi M, Kohli HS, Gupta KL, et al. PLA2R antibodies, glomerular PLA2R deposits and variations in PLA2R1 and HLA-DQA1 genes in primary membranous nephropathy in South Asians. Nephrol Dial Transpl. 2016;31(9):1486\u201393.","journal-title":"Nephrol Dial Transpl"},{"issue":"1","key":"4802_CR33","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1186\/s12882-016-0407-3","volume":"17","author":"YC Ge","year":"2016","unstructured":"Ge YC, Jin B, Zeng CH, Zhang MC, Chen DC, Yin R, Le WB. PLA2R antibodies and PLA2R glomerular deposits in psoriasis patients with membranous nephropathy. BMC Nephrol. 2016;17(1):185.","journal-title":"BMC Nephrol"},{"issue":"2","key":"4802_CR34","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1159\/000188882","volume":"72","author":"T Sakemi","year":"1996","unstructured":"Sakemi T, Hayashida R, Ikeda Y, Baba N, Nishihara G, Kohda H. Membranous glomerulonephropathy associated with psoriasis vulgaris. Nephron. 1996;72(2):351\u20132.","journal-title":"Nephron"},{"issue":"1","key":"4802_CR35","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s11255-021-02851-5","volume":"54","author":"J Peng","year":"2022","unstructured":"Peng J, Cao L. A case of idiopathic membranous nephropathy and psoriasis vulgaris. Int Urol Nephrol. 2022;54(1):237\u20138.","journal-title":"Int Urol Nephrol"},{"issue":"6","key":"4802_CR36","doi-asserted-by":"publisher","first-page":"682","DOI":"10.4103\/ijdvl.IJDVL_298_18","volume":"85","author":"S Arora","year":"2019","unstructured":"Arora S, Jairam A, Radhakrishnan S, Das N, Vankalakunti M. PLA2R antibody positive membranous glomerulonephropathy associated with psoriasis vulgaris. Indian J Dermatol Venereol Leprol. 2019;85(6):682.","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"2","key":"4802_CR37","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.ajpath.2013.04.017","volume":"183","author":"A Migliorini","year":"2013","unstructured":"Migliorini A, Angelotti ML, Mulay SR, Kulkarni OO, Demleitner J, Dietrich A, Sagrinati C, Ballerini L, Peired A, Shankland SJ, et al. The antiviral cytokines IFN-\u03b1 and IFN-\u03b2 modulate parietal epithelial cells and promote podocyte loss. Am J Pathol. 2013;183(2):431\u201340.","journal-title":"Am J Pathol"},{"key":"4802_CR38","doi-asserted-by":"crossref","unstructured":"Kopp JB, Anders H-J, Susztak K, Podest\u00e0 MA, Remuzzi G, Hildebrandt F, Romagnani P. Podocytopathies. Nat Reviews Disease Primers. 2020;6(1).","DOI":"10.1038\/s41572-020-0196-7"},{"key":"4802_CR39","doi-asserted-by":"crossref","unstructured":"Nystrom SE, Li G, Datta S, Soldano KL, Silas D, Weins A, Hall G, Thomas DB, Olabisi OA. JAK inhibitor blocks COVID-19 cytokine-induced JAK\/STAT\/APOL1 signaling in glomerular cells and podocytopathy in human kidney organoids. JCI Insight. 2022;7(11).","DOI":"10.1172\/jci.insight.157432"},{"issue":"7","key":"4802_CR40","doi-asserted-by":"publisher","first-page":"433","DOI":"10.31128\/AJGP-08-19-5035","volume":"49","author":"BS Daniel","year":"2020","unstructured":"Daniel BS. The multiple comorbidities of psoriasis: the importance of a holistic approach. Aust J Gen Pract. 2020;49(7):433\u20137.","journal-title":"Aust J Gen Pract"},{"issue":"4","key":"4802_CR41","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.jaad.2012.08.015","volume":"68","author":"AW Armstrong","year":"2013","unstructured":"Armstrong AW, Harskamp CT, Armstrong EJ. Psoriasis and metabolic syndrome: a systematic review and meta-analysis of observational studies. J Am Acad Dermatol. 2013;68(4):654\u201362.","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"4802_CR42","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.jaad.2015.01.004","volume":"72","author":"M Gyldenlove","year":"2015","unstructured":"Gyldenlove M, Storgaard H, Holst JJ, Vilsboll T, Knop FK, Skov L. Patients with psoriasis are insulin resistant. J Am Acad Dermatol. 2015;72(4):599\u2013605.","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"4802_CR43","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1097\/HJH.0b013e32835bcce1","volume":"31","author":"AW Armstrong","year":"2013","unstructured":"Armstrong AW, Harskamp CT, Armstrong EJ. The association between psoriasis and hypertension: a systematic review and meta-analysis of observational studies. J Hypertens. 2013;31(3):433\u201342. discussion 442\u2009\u2013\u2009433.","journal-title":"J Hypertens"},{"issue":"8","key":"4802_CR44","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.2337\/dc12-2330","volume":"36","author":"U Khalid","year":"2013","unstructured":"Khalid U, Hansen PR, Gislason GH, Lindhardsen J, Kristensen SL, Winther SA, Skov L, Torp-Pedersen C, Ahlehoff O. Psoriasis and new-onset diabetes: a Danish nationwide cohort study. Diabetes Care. 2013;36(8):2402\u20137.","journal-title":"Diabetes Care"},{"issue":"6","key":"4802_CR45","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1016\/j.jaad.2015.02.1095","volume":"72","author":"AW Armstrong","year":"2015","unstructured":"Armstrong AW, Guerin A, Sundaram M, Wu EQ, Faust ES, Ionescu-Ittu R, Mulani P. Psoriasis and risk of diabetes-associated microvascular and macrovascular complications. J Am Acad Dermatol. 2015;72(6):968\u2013e977962.","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"4802_CR46","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1093\/bjd\/ljae199","volume":"191","author":"SP Parraga","year":"2024","unstructured":"Parraga SP, Feldman SR. Insulin resistance and psoriasis. Br J Dermatol. 2024;191(4):486\u20137.","journal-title":"Br J Dermatol"},{"issue":"5","key":"4802_CR47","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.jnutbio.2007.06.006","volume":"19","author":"C Zou","year":"2008","unstructured":"Zou C, Shao J. Role of adipocytokines in obesity-associated insulin resistance. J Nutr Biochem. 2008;19(5):277\u201386.","journal-title":"J Nutr Biochem"},{"issue":"6","key":"4802_CR48","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/S1578-2190(07)70472-9","volume":"98","author":"L Puig Sanz","year":"2007","unstructured":"Puig Sanz L. Psoriasis, a systemic disease? Actas Dermo-Sifiliogr\u00e1ficas (English Edition). 2007;98(6):396\u2013402.","journal-title":"Actas Dermo-Sifiliogr\u00e1ficas (English Edition)"},{"issue":"3","key":"4802_CR49","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jaad.2016.07.064","volume":"76","author":"J Takeshita","year":"2017","unstructured":"Takeshita J, Grewal S, Langan SM, Mehta NN, Ogdie A, Van Voorhees AS, Gelfand JM. Psoriasis and comorbid diseases. J Am Acad Dermatol. 2017;76(3):377\u201390.","journal-title":"J Am Acad Dermatol"},{"key":"4802_CR50","doi-asserted-by":"publisher","first-page":"16082","DOI":"10.1038\/nrdp.2016.82","volume":"2","author":"JE Greb","year":"2016","unstructured":"Greb JE, Goldminz AM, Elder JT, Lebwohl MG, Gladman DD, Wu JJ, Mehta NN, Finlay AY, Gottlieb AB. Psoriasis. Nat Rev Dis Primers. 2016;2:16082.","journal-title":"Nat Rev Dis Primers"},{"key":"4802_CR51","doi-asserted-by":"crossref","unstructured":"Fujii Y, Takeichi T, Yamashita Y, Okumura T, Sakakibara A, Muro Y, Akiyama M. Concurrent wild-type transthyretin amyloidosis and psoriasis vulgaris in an elderly man. J Dermatol. 2025;52(6).","DOI":"10.1111\/1346-8138.17670"},{"key":"4802_CR52","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.2147\/ITT.S527251","volume":"14","author":"R Cui","year":"2025","unstructured":"Cui R, Wang Q, Kang ZJ, Du Y, Chen M, Wang YH, Wei JC, Dai SM. Psoriasis increases the risk of ANCA associated vasculitis: insights from A propensity Score-Matched study. Immunotargets Ther. 2025;14:1087\u201395.","journal-title":"Immunotargets Ther"},{"issue":"2","key":"4802_CR53","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1007\/s13730-024-00927-6","volume":"14","author":"T Sugiura","year":"2025","unstructured":"Sugiura T, Doke T, Tanaka A, Sato Y, Maeda K, Furuhashi K, Kato N, Kosugi T, Maruyama S. MPO-ANCA-positive rapidly progressive glomerulonephritis after COVID-19 vaccination during treatment of plaque psoriasis with Bimekizumab. CEN Case Rep. 2025;14(2):194\u20139.","journal-title":"CEN Case Rep"},{"issue":"10","key":"4802_CR54","doi-asserted-by":"publisher","first-page":"e1430","DOI":"10.1002\/mgg3.1430","volume":"8","author":"L Wei","year":"2020","unstructured":"Wei L, Fang Y, Cao G, Zhang S, Tian M, Shen Q, Xu H, Liu C, Rao J. Genetic and pathological findings in a Boy with psoriasis and C3 glomerulonephritis: A case report and literature review. Mol Genet Genomic Med. 2020;8(10):e1430.","journal-title":"Mol Genet Genomic Med"},{"issue":"1","key":"4802_CR55","doi-asserted-by":"publisher","first-page":"117","DOI":"10.7150\/thno.48624","volume":"11","author":"R Luo","year":"2021","unstructured":"Luo R, Cheng Y, Chang D, Liu T, Liu L, Pei G, Zhang N, Wang Z, Guo K, Chen W, et al. Tertiary lymphoid organs are associated with the progression of kidney damage and regulated by interleukin-17A. Theranostics. 2021;11(1):117\u201331.","journal-title":"Theranostics"},{"issue":"1","key":"4802_CR56","doi-asserted-by":"publisher","first-page":"4866","DOI":"10.1038\/s41598-024-55425-7","volume":"14","author":"MG Uriol-Rivera","year":"2024","unstructured":"Uriol-Rivera MG, Obrador-Mulet A, Julia MR, Daza-Cajigal V, Delgado-Sanchez O, Garcia Alvarez A, Gomez-Lobon A, Carrillo-Garcia P, Saus-Sarrias C, Gomez-Cobo C, et al. Sequential administration of paricalcitol followed by IL-17 Blockade for progressive refractory IgA nephropathy patients. Sci Rep. 2024;14(1):4866.","journal-title":"Sci Rep"},{"key":"4802_CR57","doi-asserted-by":"crossref","unstructured":"Chung EYM, Wang YM, Shaw K, Ronning E, Wang Y, Yu Zhang G, Hu M, Keung K, McCarthy HJ, Harris DCH, et al. T cell costimulatory Blockade ameliorates induction of experimental membranous nephropathy potentially through T-helper 17 cell suppression in the kidney. Nephrol Dial Transpl. 2025.","DOI":"10.1093\/ndt\/gfaf030"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-026-04802-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-026-04802-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-026-04802-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T17:02:42Z","timestamp":1770915762000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12882-026-04802-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,4]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4802"],"URL":"https:\/\/doi.org\/10.1186\/s12882-026-04802-7","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,4]]},"assertion":[{"value":"12 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethics Committee and Institutional Review Board of Shanghai Ruijin Hospital. Informed consent to participate was obtained from all the participants in our study. Our study adhered to the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"114"}}